IP Library Granted Patent US 9,067,026
Granted Patent B2
US 9,067,026 · App. 13/320,966 · Granted Jun 30, 2015

Vascular graft

Inventors: Peter Arno Stonebridge (Perth, GB); John Bruce Cameron Dick (Coupar Angus Blairgowrie, GB); John Graeme Houston (Perth Tayside, GB); Robert Gordon Hood (Longforgan Tayside, GB)
Assignee: Vascular Flow Technologies Limited
A61M1/3655A61F2/88A61F2/06A61M39/0208A61M2206/12F15D1/065A61B17/11A61F2/07B29C45/14622A61B2017/1107A61M1/3653A61F2002/068A61M2206/16
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,067,026
App. No.
13/320,966
Granted
Jun 30, 2015
Kind
B2
Abstract

A vascular access graft ( 1 ) comprises an elongate conduit ( 2 ) having proximal and distal ends ( 3, 4 ). At least a portion of the elongate conduit ( 2 ) has a self-sealing property such that the portion remains impermeable after puncturing by a dialysis needle. The vascular access graft ( 1 ) also comprises a helical fin ( 6 ) projecting inwardly from the inner surface ( 5 ) of the elongate conduit ( 2 ) and extending parallel to the axis of the elongate conduit ( 2 ).

Claims (27)

1. A vascular access graft comprising:

an elongate conduit having distal and proximal ends and a length therebetween, an inner surface, an exterior and longitudinal axis, at least a portion of the elongate conduit having a self-sealing property such that the portion remains impermeable after puncturing by a dialysis needle; and

a helical fin projecting inwardly from the inner surface of the elongate conduit, having a first and a second end and a length therebetween, and extending parallel to the longitudinal axis of the elongate conduit, wherein the helical fin extends from the distal end of the elongate conduit to a termination point which is short of the proximal end of the elongate conduit; and

an external palpable protrusion positioned on the exterior of the elongate conduit, wherein the positioning of the protrusion on the elongate conduit corresponds to the position of the termination point of the helical fin between the distal and proximal ends of the elongate conduit.

2. A vascular access graft comprising:

an elongate conduit having distal and proximal ends and a length therebetween, an inner surface, an exterior and longitudinal axis, at least a portion of the elongate conduit having a self-sealing property such that the portion remains impermeable after puncturing by a dialysis needle;

a helical fin projecting inwardly from the inner surface of the elongate conduit, having a first and a second end and a length therebetween, and extending parallel to the longitudinal axis of the elongate conduit,

wherein the helical fin consists of between 80% and 120% of one single revolution,

wherein the helical fin extends from the distal end of the elongate conduit to a termination point which is short of the proximal end of the elongate conduit; and

an external palpable protrusion positioned on the exterior of the elongate conduit, wherein the positioning of the protrusion on the elongate conduit corresponds to the position of the termination point of the helical fin between the distal and proximal ends of the elongate conduit.

3. The vascular access graft according to claim 1 wherein the helical fin has a helix angle of between 5° and 20°.

4. The vascular access graft according to claim 3 wherein the helix angle of the helical fin changes over the length of the helical fin.

5. The vascular access graft according to claim 1 wherein the helical fin consists of between 50% and 150% of one single revolution.

6. The vascular access graft according to claim 2 wherein the external palpable protrusion is a palpable ring which completely or partially encircles the exterior of the elongate conduit.

7. The vascular access graft according to claim 2 wherein the external palpable protrusion extends between 1 mm and 4 mm from the exterior of the elongate conduit.

8. The vascular access graft according to claim 2 wherein the external palpable protrusion has a length of between 3 mm and 6 mm along the length of the elongate conduit.

9. The vascular access graft according to claim 1 further comprising an external helical formation extending axially around the exterior of the elongate conduit, for supporting the elongate conduit.

10. The vascular access graft according to claim 9 wherein the helix angle of the external helical formation is greater than the helix angle of the helical fin.

11. The vascular access graft according to claim 9 wherein the external helical formation has a helix angle of greater than 50°.

12. The vascular access graft according to claim 2 further comprising an axially extending external deformation helix located around the exterior of the elongate conduit, wherein the axially extending external deformation helix deforms the elongate conduit so as to provide the helical fin projecting inwardly from the inner surface of the elongate conduit, such that the helical fin corresponds to the axially extending external deformation helix, and wherein the external palpable protrusion is an integral part of the deformation helix.

13. The vascular access graft according to claim 12 wherein the elongate conduit is made from ePTFE, and the axially extending external deformation helix and external palpable protrusion are made from polyurethane.

14. The vascular access graft according to claim 2 wherein the helical fin extends from the distal end of the elongate conduit for less than 25% of the total length of the elongate conduit.

15. The vascular access graft according to claim 2 wherein the helical fin extends from the distal end of the elongate conduit for less than 15% of the total length of the elongate conduit.

16. The vascular access graft according to claim 1 wherein the helical fin has a helix angle of between 8° and 16°.

17. The vascular access graft according to claim 1 wherein the helical fin consists of between 80% and 120% of one single revolution.

18. The vascular access graft according to claim 2 wherein the external palpable protrusion extends 2 mm from the exterior of the elongate conduit.

19. The vascular access graft according to claim 2 wherein the helical fin extends from the distal end of the elongate conduit for less than 50% of the total length of the elongate conduit.

Assignments (2)
CHANGE OF NAME Recorded May 20, 2015
From: TAYSIDE FLOW TECHNOLOGIES LIMITED
To: VASCULAR FLOW TECHNOLOGIES LIMITED
Reel/Frame 035683/0224 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 10, 2012
From: STONEBRIDGE, PETER ARNO; DICK, JOHN BRUCE CAMERON; HOUSTON, JOHN GRAEME; HOOD, ROBERT GORDON
To: TAYSIDE FLOW TECHNOLOGIES LTD.
Reel/Frame 027683/0318 →
Priority Claims (2)
GB 0908614.1 · May 19, 2009 · national
GB 1003334.8 · Feb 26, 2010 · national
Continuity (1)
Related Publication 20120130314A1 · May 24, 2012